Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu hodnotící studie, časopisecké články
- MeSH
- bezpečnost vybavení MeSH
- časové faktory MeSH
- design vybavení MeSH
- dospělí MeSH
- infekce spojené s protézou etiologie MeSH
- infekce vyvolané Escherichia coli komplikace MeSH
- katetrizace centrálních vén škodlivé účinky přístrojové vybavení MeSH
- lidé středního věku MeSH
- lidé MeSH
- migrace cizích těles etiologie MeSH
- nádory farmakoterapie MeSH
- následné studie MeSH
- odstranění implantátu MeSH
- protinádorové látky aplikace a dávkování MeSH
- pseudomonádové infekce komplikace MeSH
- senioři MeSH
- sepse etiologie MeSH
- venae jugulares chirurgie MeSH
- vřed etiologie MeSH
- výsledek terapie MeSH
- zaváděcí katétry škodlivé účinky MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
- Názvy látek
- protinádorové látky MeSH
AIM OF WORK: Evaluation of suitability and safety of venous port implantation with catheter insertion via the right internal jugular vein in oncology patients. PATIENTS AND METHODS: One hundred one totally implantable venous ports were placed in 100 patients with malignancies from January 1, 2003 until March 31, 2005. Catheter of venous port was preferably inserted via the right internal jugular vein. We recorded a number of successful implantations using this venous approach and the rate of complications during the procedure and follow-up. MAIN RESULTS: Ninety-seven catheters (96%) of totally implantable venous ports were inserted via the right internal jugular vein in 96 patients, and only in four cases were we not able to access this vein. We had no complications related to catheter insertion via the right internal jugular vein. Follow-up was made in all 96 patients with a total access days of 41 in 151 days (mean: 407 days). Premature catheter removal was required in six (6.2%, 0.144 per 1,000 access days) due to complications: three catheter dislocations/malfunctions (3.1%, 0.072 per 1,000 access days), one port-related sepsis, one pocket port infection, and one decubitus over port (1%, 0.024 per 1,000 access days). Six venous ports were removed after completion of the treatment at the patient's request. CONCLUSION: The placement of totally implantable venous ports with catheter insertion via the right internal jugular vein has a high success rate without any early complications. Follow-up also demonstrates a low incidence of late complications requiring port removal.
Zobrazit více v PubMed
J Vasc Interv Radiol. 1997 Nov-Dec;8(6):991-5 PubMed
Radiology. 1992 Jul;184(1):149-51 PubMed
Acta Oncol. 1999;38(8):1103-7 PubMed
Am J Med. 1982 Dec;73(6):841-5 PubMed
J Clin Oncol. 1999 Apr;17(4):1267 PubMed
Surg Gynecol Obstet. 1979 Jun;148(6):871-5 PubMed
Ann Oncol. 1998 Jul;9(7):767-73 PubMed
World J Surg. 1998 Jan;22(1):12-6 PubMed
Thromb Haemost. 1996 Feb;75(2):251-3 PubMed
AJR Am J Roentgenol. 1997 Nov;169(5):1431-4 PubMed
Surg Gynecol Obstet. 1973 Apr;136(4):602-6 PubMed
Eur Radiol. 1996;6(5):748-52 PubMed
Eur J Cancer Clin Oncol. 1989 Jun;25(6):939-44 PubMed
J Neurosurg Anesthesiol. 1996 Oct;8(4):286-92 PubMed
Cardiovasc Intervent Radiol. 1997 Jan-Feb;20(1):17-22 PubMed
AJR Am J Roentgenol. 2001 Apr;176(4):991-4 PubMed
Br J Cancer. 1996 May;73(10):1260-4 PubMed
Acta Radiol. 2002 Jul;43(4):371-5 PubMed
